<DOC>
	<DOCNO>NCT00452543</DOCNO>
	<brief_summary>This study treatment people suffer major depression alcohol abuse dependence . The study examine whether addition acamprosate escitalopram behavioral intervention improve outcome population .</brief_summary>
	<brief_title>Acamprosate Added Escitalopram Behavioral Treatment Comorbid Depression Alcoholism</brief_title>
	<detailed_description>Depression alcohol use disorder contribute significant proportion burden disease , United States abroad . Patients suffer co-morbid depression alcohol abuse/dependence illness severe , persistent costly people either depression alcohol use disorder alone . The treatment patient remain controversial . Several study demonstrate antidepressant safe efficacious treatment depression people continue drink , consider standard care provide treatment . Other study show pharmacotherapy naltrexone acamprosate help reduce drink alcoholic without co-morbid depression . A logical extension finding would study treatment depressed alcoholic dual pharmacotherapy , combine anti-depressant medication aim treat alcohol use disorder . We conduct randomize , double-blind , placebo control trial escitalopram plus acamprosate behavioral treatment vs. escitalopram plus placebo behavioral treatment 20 depressed alcoholic . Outcome measure include depression , alcohol use global functioning .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>1 . DSMIV diagnostic criterion MDD ( diagnosis base Structured Clinical Interview DSMIV , Patient Edition ; SCID I/P ) 2 . Written inform consent 3 . Men woman age 1864 year 4 . Current diagnosis alcohol abuse/dependence per SCID I/P 1 . Subjects suicidal ideation outpatient treatment determine unsafe study clinician . These patient immediately refer appropriate clinical treatment . 2 . Pregnant woman woman childbearing potential use medically accept mean contraception ( defined oral contraceptive pill implant , condom , diaphragm , spermicide , IUD , s/p tubal ligation , partner vasectomy ) . 3 . Known history serious unstable medical illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic hematologic disease . 4 . History seizure disorder , brain injury , history know neurological disease ( multiple sclerosis , degenerative disease ALS , Parkinson disease movement disorder , etc. ) . 5 . Clinical lab evidence untreated hypothyroidism . 6 . History current diagnosis follow DSMIV psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , bipolar disorder , patient mood congruent mood incongruent psychotic feature , patient substance use disorder ( exclude alcohol nicotine ) active within last 12 month . 7 . Current use psychotropic drug , include current use benzodiazepine , hypnotic , anticonvulsant . Concomitant use antihistamine drug allow . Patients need antidepressant least two week time baseline visit , four week fluoxetine , benzodiazepine psychotropics least one week . The decision whether taper exist medication make individual primary treater base clinical care make purpose study enrollment . allow . 8 . Patients fail respond course current major depressive episode least two adequate antidepressant trial . An adequate antidepressant trial define six week treatment escitalopram &gt; 20mg/day antidepressant equivalent : ( fluoxetine 40mg/day , sertraline &gt; 100 mg/day , paroxetine &gt; 40 mg/day , fluvoxamine &gt; 100 mg/day , citalopram &gt; 40 mg/day , escitalopram &gt; 20 mg/day , venlafaxine &gt; 150 mg/day , duloxetine &gt; 60 mg/day ) . 9 . Any depressionfocused substanceabuse focus psychotherapy ( family marital counseling would allow ) . 10 . Patients take investigational psychotropic drug within past year . 11 . Need medical inpatient detoxification alcohol . This determination make screen clinician , base clinical judgement multicenter STAR*D study ( PHRC # 2000P001955 accordance method use multicenter STARD study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Major depressive disorder</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol abuse</keyword>
	<keyword>Alcohol dependence</keyword>
</DOC>